Getinge AB (publ) (OTCMKTS:GNGBY – Get Free Report) was the recipient of a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 700 shares, a growth of 600.0% from the October 31st total of 100 shares. Based on an average daily trading volume, of 83,900 shares, the short-interest ratio is presently 0.0 days.
Getinge AB (publ) Stock Up 1.2 %
GNGBY stock opened at $15.31 on Thursday. The business has a 50 day moving average of $18.89 and a 200-day moving average of $18.77. Getinge AB has a 12-month low of $14.84 and a 12-month high of $22.85.
Getinge AB (publ) (OTCMKTS:GNGBY – Get Free Report) last announced its quarterly earnings data on Friday, October 18th. The company reported $0.21 earnings per share (EPS) for the quarter. Getinge AB (publ) had a return on equity of 8.27% and a net margin of 5.04%. The firm had revenue of $755.49 million during the quarter.
Getinge AB (publ) Company Profile
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.
See Also
- Five stocks we like better than Getinge AB (publ)
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Investing in Commodities: What Are They? How to Invest in Them
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Getinge AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.